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Background: A single nucleotide polymorphism (SNP, rs2200733) on chromosome 4q25 is strongly associated with atrial fibrillation (AF). The 
biological significance of this SNP is unknown, but it is located near and may modulate expression of a transcription factor, PITX2. As a link between 
PITX2 and endothelin-1 (ET-1) signaling has been suggested, we hypothesized that the 4q25 SNP may modulate ET-1 signaling.
Methods: The rs2200733 SNP was genotyped in a lone AF cohort. To test whether the SNP is correlated with plasma ET-1 levels (pET1), ET-1 was 
assessed by ELISA (Biomedica BI-20052) in plasma samples from 119 individuals (30 TT, homozygous for the risk allele; 43 CT heterozygous, and 46 
CC homozygous for the major allele). Groups were matched for age, gender and hypertension (HT).
Results: Box plots (median, 25th, 75th percentile) show that pET1 levels were higher in lone AF patients homozygous for the risk allele (TT, 
p<0.0006) than in the CT or CC patients. Data support an additive rather than dominant model. Univariate predictors of pET1 levels also included 
age and systolic blood pressure (BP), but not diastolic BP or BMI. In a multivariate model, genotype, followed by age, were the strongest and only 
significant predictors.
Conclusions: The SNP rs2200733 is strongly associated with plasma ET-1 levels in lone AF patients. ET-1 is associated with HT, modulates myocyte 
calcium cycling, and promotes cardiac hypertrophy and fibrosis. ET-1 may contribute to the increased risk of AF in subjects with this genotype.
